Guidance maps clearance process for trials of knee cartilage products

01/20/2012 | MassDevice.com (Boston)

New guidance from the FDA outlines the process for obtaining clearance for clinical studies of devices, combination products and biologics designed to replace or repair knee cartilage. The guidance requires manufacturers seeking investigational device exemption to submit documents describing materials used, individual elements, anticipated product changes and related data.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Chief Medical Officer
Meritus
Tempe, AZ
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX